What Knowles (KN) Said on Its Q3 Earnings Call
Knowles (KN) reported Q3 earnings, highlighting capacity expansion plans and strong demand in precision devices and hearing health. Revenue grew 4% YoY in med tech and specialty audio. The company expects 14% YoY revenue growth in Q4 and 16% for 2026, with margin expansion. Knowles also announced a $15M defense order and plans for increased capital spending in 2027.
How this was made

The 30-second read
Why it matters
The guidance suggests accelerated growth and margin expansion, likely supporting a price rally.
Market read
First disclosure of detailed 2027 guidance; material for traders evaluating KN and sector peers.
What to watch
Potential supply‑chain constraints and the $15 M defense order spread over 36 months may limit near‑term cash.
Background
Knowles (NYSE:KN) reported Q3 results and provided 2027 outlook, including capacity additions and share repurchase.
Ticker impact
Q3 earnings call disclosed new 2027 guidance, capacity expansion timeline, and share repurchase details.
upward pressure as investors price in higher growth and margin outlook
Guidance exceeds prior expectations and includes higher capital spending, indicating confidence in demand.
Market effects
Positive signal for precision devices and med‑tech audio components, may lift peers.
U.S. technology sector could see modest gains.
Limited to companies with similar product lines; no broad macro effect.
Counterpoint
Higher capital spending could strain cash flow if demand softens, risking margin pressure.
Key entities
- companyKnowles Corporation
Manufacturer of precision devices and med‑tech audio components.
- executiveJohn Anderson
Chief Financial Officer providing guidance details.

